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Hydrophobic mismatchavailable regarding the inﬂuence of membrane environment on transmembrane
(TM) G-protein-coupled receptor (GPCR) conformation and dynamics. The human CB1 cannabinoid receptor
(hCB1) is a prominent GPCR pharmacotherapeutic target in which helix 7 appears critical to ligand
recognition. We have chemically synthesized a hCB1 peptide corresponding to a segment of TM helix 7 and
the entire contiguous helix 8 domain (fourth cytoplasmic loop) and reconstituted it in deﬁned phospholipid-
bilayer model membranes. Using an NMR-based strategy combined with molecular dynamics simulations,
we provide the ﬁrst direct experimental description of the orientation of hCB1 helix 7 in phospholipid
membranes of varying thickness and the mechanism by which helix-7 conformation adjusts to avoid
hydrophobic mismatch. Solid-state 15N NMR data show that hCB1 helices 7 and 8 reconstituted into
phospholipid bilayers are oriented in a TM and in-plane (i.e., parallel to the phospholipid membrane surface)
fashion, respectively. TM helix orientation is inﬂuenced by the thickness of the hydrophobic membrane
bilayer as well as the interaction of helix 8 with phospholipid polar headgroups. Molecular dynamics
simulations show that a decrease in phospholipid chain-length induces a kink at P394 in TM helix 7 to avoid
hydrophobic mismatch. Thus, the NP(X)nY motif found in hCB1 and highly conserved throughout the GPCR
superfamily is important for ﬂexing helix 7 to accommodate bilayer thickness. Dynamic modulation of hCB1-
receptor TM helix conformation by its membrane environment may have general relevance to GPCR
structure and function.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionIncorporation of a protein transmembrane (TM) domain into a
membrane lipid bilayer is driven by the hydrophobic effect
associated with free-energy minimization of the system and the
interplay between the hydrophobic length of the membrane-
spanning protein segment and the thickness of the membrane
phospholipid bilayer [1–3]. Discrepancy between the length of the
hydrophobic domain of a membrane-spanning protein and bilayer
thickness (“hydrophobic mismatch”) has adverse consequences for
cellular processes such as protein sorting along the secretoryptor; GPCR, G-protein-coupled
ne]sulfonic acid; TFE, triﬂuor-
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ll rights reserved.pathway and membrane stability [4]. Hydrophobic mismatch may
also inﬂuence the orientation of protein TM helices as a function of
their hydrophobic length, an effect observed at the molecular level in
model systems involving synthetic hydrophobic peptides and
hydrated membrane vesicles composed of phospholipids with
differing chain lengths [5–7].
Hydrophobic mismatch can be compensated for in various ways
[6,8,9]. The membrane bilayer region surrounding the imbedded
protein segment may adjust its thickness in accord with the length of
the hydrophobic TM protein region. Should the length of the protein's
TM region exceed the thickness of its surrounding lipid bilayer, either
protein tilting or a kink at a proline residue would reduce its effective
length across the bilayer. Proline residues are well-known α-helical
destabilizers in globular proteins, and many biologically important
peptide sequences contain proline [10]. For example, the NP(X)nY
motif conserved throughout the G-protein-coupled receptor (GPCR)
superfamily is considered to play a signiﬁcant role in signal
transduction at the level of select GPCR TM helices [10,11].
The endogenous cannabinoid (CB) (endocannabinoid) signaling
system is implicated in a variety of (patho)physiological processes,
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(endocannabinoids) that function as agonists for two membrane-
bound, metabotropic CB GPCRs of the 1A, rhodopsin-like family. The
general architecture of these CB receptors is deﬁned by an extra-
cellularly oriented N-terminus, an intracellular carboxyl terminus, and
a counterclockwise arrangement of seven hydrophobic TM α-helices
which span the cell membrane and are connected by three
extracellular and three cytoplasmic loops [12,13]. The CB1 receptor
subtype is the most abundant brain GPCR and centrally controls
motor, cognitive, emotional, and sensory functions to inﬂuence pain
perception, hormonal activity, thermoregulation, and cardiovascular,
gastrointestinal, and respiratory physiology. Activation of central CB1
receptors also mediates most cannabinoid psychotropic and beha-
vioral effects that reﬂect the psychoactivity of the marijuana
phytocannabinoid, Δ9-tetrahydrocannabinol. CB1 receptors at various
peripheral sites (e.g., liver, adipocytes, endocrine pancreas) help
regulate energy metabolism and other fundamental physiological
processes [13,14]. Hyperactive CB1-receptor transmission has been
implicated in many common diseases having a reward-supported
component, such as overweight/obesity and substance abuse dis-
orders [15]. Indeed, the ﬁrst major drug to emerge from rational
discovery efforts aimed at endocannabinoid-system modulation
reached the market as a CB1-receptor antagonist for weight-control
[16]. The CB1 receptor, accordingly, has gained intense current interest
inmedicinal chemistry as a therapeutic target for designer ligands and
as the focus of research aimed at deﬁning its ligand-binding
architecture for therapeutic gain [15,17].
Four potential pharmacological modes of CB1 receptor–ligand
interaction have been recognized: agonism, inverse agonism, antag-
onism, and allosterism [13,18]. Ligand binding motifs and pharmaco-
logical responses for the CB1 receptor and other GPCRs have been
attributed to speciﬁc GPCR TM helix conformations and orientations
within the cell membrane bilayer [19,20]. Conformational exchange in
the micro-millisecond regime is important to the binding and
pharmacodynamics of GPCR ligands, and helices 7 and 8 are
considered critical to the stability of the GPCR-G-protein interaction
at the cytoplasmic C-terminus [21]. Thus, information on GPCR TM
helix structure and orientation appears essential to understanding the
(patho)physiological roles of endogenous cannabinoids and elucidat-
ing the pharmacophore requirements for synthetic CB1-receptor
ligands as potential drugs. Largely because of inherent difﬁculties in
isolating structurally preserved GPCRs from their membrane environ-
ments for analysis by X-ray crystallography and nuclear magnetic
resonance (NMR) spectroscopy, direct, experimentally-derived data
on GPCR structure and ligand recognition are limited. Notwithstand-
ing descriptions of the crystal structures of bovine rhodopsin [22], an
engineered, human β2-adrenergic receptor [23], the ligand-free opsin
receptor [24], and the β1-adrenergic receptor–cyanopindolol complex
[25], the structural details and conformational plasticity of CB
receptors remain incompletely understood. The three-dimensional
rhodopsin structure has been employed to derive CB-receptor
homology models, which must remain speculative due to the
attendant extrapolations involved [26–28]. Although some features
of the CB1 receptor are reminiscent of rhodopsin and other GPCRs
[22,27,29], the orientations of CB1-receptor helices need not be
identical to those of other GPCRs whose three-dimensional structures
have been solved. Computational andmutation studies have predicted
the importance of helices 7 and 8 to CB1-receptor structure and
function [29–31] and, in particular, the inﬂuence of helix-7 conforma-
tion to CB1-receptor ligand recognition [29,32,33]. These considera-
tions mandate direct experimental characterization of the orientation
of CB1-receptor TM helices within the membrane lipid environment
and the factors inﬂuencing helix orientation and CB1 receptor-
membrane cooperativity.
Chemically synthesized peptides corresponding to TM segments of
naturally-occurring membrane proteins in aligned phospholipid-bilayer model membranes have proven to be useful experimental
systems for gaining insight into the secondary structure of such
proteins [34,35]. We have previously provided evidence that CB1-
receptor helix 8 assumes an α-helical character in an amphipathic
environment [29]. In this study, we have synthesized a human CB1
(hCB1) receptor fragment, hCB1(T377-E416), consisting of a segment
of TM helix 7 and the entire helix 8 and reconstituted this peptide into
phospholipid bilayers of known compositions. By utilizing circular
dichroism spectropolarimetry (CD), solid-state NMR spectroscopy,
and molecular dynamics (MD) simulations, we detail the orientation
of hCB1 helix 7 in these bilayermembranemimetics and identify some
of the peptide's conformational determinants. Mechanically oriented,
selectively 15N-labeled hCB1(T377-E416) peptides allowed us to
demonstrate unambiguously the presence of two α-helical peptide
components at almost orthogonal orientation within 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC; 1,2–14:0) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospocholine (POPC; 1–16:0, 2–18:1) phospho-
lipid bilayer environments. To determine the precise orientation of TM
helix 7, the chemical shifts of six singly 15N-labeled, mechanically
oriented hCB1(T377-E416) peptides were studied in DMPC and POPC
phospholipid bilayers. The 15N chemical shifts obtained from the six
singly labeled spectra were used to deﬁne the helical tilt of the hCB1
(T377-E416) peptide. Finally, MD simulations of hCB1(T377-E416) in
DMPC and POPC bilayers were performed. To the authors' best
knowledge, this is the ﬁrst application of solid-state NMR spectro-
scopy to characterize directly the structural dynamics of CB-receptor
helices within (model) membranes.
2. Materials and methods
2.1. Materials
POPC and DMPC in chloroform were purchased from Avanti Polar
Lipids (Alabaster, AL) and stored at −20 °C. 2,2,2-Triﬂuoroethanol
(TFE), N-[2-hydroxyethylpiperazine-N′-2-ethane]sulfonic acid
(HEPES), and EDTA were obtained from Sigma-Aldrich (Milwaukee,
WI). Deuterium-depleted water was purchased from Sigma-Aldrich
(St. Louis, MO). Dodecylphosphocholine (DPC) was purchased from
Cambridge Isotopic Laboratories (Andover, MA). All other chemicals
were purchased from Sigma-Aldrich at highest available grade.
2.2. Peptide synthesis and puriﬁcation
The numbering system of Bramblett et al. is employed [28]. Peptide
corresponding to hCB1(T377-E416) (TVFAFCSMLCLLNSTVN-
PIIYALRSKDLRHAFRSMFPSCE) was synthesized using a 433A Peptide
Synthesizer (Applied Biosystems, Foster City, CA) equipped for 9H-
ﬂuoren-9-ylmethoxycarbonyl (Fmoc) chemistry at the Molecular
Biology Core Facility, Dana-Farber Cancer Institute (Boston, MA). All
amino acids were single coupled, with a total of 9.5 min for the
coupling and monitoring module. The peptide was puriﬁed on a
Dynamax SD-200 LC system (Varian Instruments, Walnut Creek, CA)
equipped with an Applied Biosystems 1000S diode array detector and
Dynamax Method Manager (version 1.4.6) software and analyzed by
MALDI-TOF mass spectrometry using an α-cyano-4-hydroxycinnamic
acid calibrationmatrix. As estimated from the LC andMALDI-TOF data,
peptide purity was 95% (data not shown).
2.3. Circular dichroism spectropolarimetry (CD)
The conformation of the hCB1(T377-E416) peptide was deter-
mined by CD using a nitrogen-ﬂushed J-810 spectropolarimeter
controlled by Spectra Manager software (version 1.15.00) (Jasco
Instruments, Easton, MD) [36]. Although not capable of providing
the residue-speciﬁc information available from NMR and X-ray
crystallography, CD measurements can be made on small amounts
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from changes in environmental conditions (e.g., pH, temperature) can
be monitored [37]. The peptide concentration was 60 μM. A 1-cm
quartz cuvette (1-mm pathlength) was used, and the HT voltage was
set at 120 mV. The spectra were recorded from 280 to 185 nm at 35 °C
with a scan rate of 1 nm/min and an average of 10 scans per sample.
The percentage α-helical content was calculated using the following
equation:
khelix= 100× θobs−θCð Þ= θH−θCð Þ;
where
θH =−40;000× 1−x=nð Þ+100T
and
θC = 640−45T:
The quantities θH and θC represent the molar ellipticity values
(deg-cm2/dmol) for 100% α-helical and 100% random coil, respec-
tively. The quantity θobs is molar ellipticity measured at 222 nm; n is
the number of amino acids, T is the temperature in Kelvin, and the
constant x=2.5 [38].
2.4. NMR sample preparation
POPC and DMPC bilayers were prepared with a 2 mol% peptide-to-
lipid ratio, i.e., with a peptide:lipid molar ratio of 1:50 [39–42]. The
15N NMR powder sample was then transferred and packed into a 4-
mm ZrO2 rotor. A hydrated sample was prepared by placing the rotor
containing the dry sample in a humidiﬁed (~93%) chamber of
saturated ammonium monophosphate. The sample was then incu-
bated for 6–12 h at 45 °C. Amechanically aligned samplewas prepared
by dissolving the hCB1(T377-E416) peptide in a minimal amount of
TFE and mixing the resulting solution with either POPC or DMPC
dissolved in chloroform (20 mg/ml) in a pear-shaped ﬂask at a 1:50
peptide-to-lipid molar ratio. Nitrogen gas was passed through the
resulting mixture until the volume of chloroformwas reduced by two-
thirds. The resulting sample was spread on 25 glass platesFig. 1. CD of hCB1(T377-E416) peptide in triﬂuoroethanol (TFE) and in 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospocholine (POPC) small unilamellar vesicles (SUVs). CD
spectra of the hCB1(T377-E416) peptide measured in 100% TFE (solid line) and in
POPC SUVs with peptide-to-lipid ratio of 1:50 (dotted line) are shown. Spectra are the
average of 10 scans.
Fig. 2. One-dimensional chemical-shift 15N NMR spectra of hCB1(T377-E416) peptide in
phospholipid bilayers. (A) The spectrum corresponding to selectively labeled 15N-[A380,
A398, K402, L404, A407, M411]hCB1(T377-E416) in oriented DMPC bilayers. (Residues
were selected to correspond to the cytosolic segments.) (B) The spectrum corresponding
to selectively labeled 15N-[A380, A398, K402, L404, A407, M411]hCB1(T377-E416) in
oriented POPC bilayers. (C) The spectrum corresponding to selectively labeled 15N-
[A380, A398, K402, L404, A407, M411]hCB1(T377-E416) in unoriented POPC bilayers.(8.5 mm×14 mm), which were dried in a desiccator overnight [35].
Deuterium-depleted water was added to the lipid–peptide mixture,
and the glass plates were stacked on top of one another. The stacked
glass plates were then placed into a humidiﬁed ammoniummonopho-
sphate chamber (relative humidity ~93%; 42 °C) until the sample
became transparent, indicating complete peptide incorporation into
the phospholipid membrane. 31P NMR of mechanically aligned DMPC
and POPC samples in the presence of the peptide indicated that the
phospholipids were well aligned with the bilayer normal, parallel to
the external magnetic ﬁeld (data not shown).
2.5. NMR spectroscopy
Solid-state 15N NMR unoriented spectra were collected utilizing a
standard cross polarization pulse sequence with 1H decoupling
between 60 and 80 kHz and a 1H–15N ﬁeld strength of 50 kHz. For
mechanically aligned samples, a double resonance ﬂat coil probe
was used operating at the required temperature in a 700 MHz
spectrometer. For the DMPC bilayer sample, the following pulse
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time, 600 ppm sweep width, and a 4 s recycle delay with 1H
decoupling. The 24 k scans were averaged and 300 Hz line
broadening was used to process the data. For the POPC sample,
the following pulse sequence parameters were used: 4.7 μs 1H 90°
pulse, 1.5 ms contact time, 500 ppm sweep width, and a 4 s recycle
delay with 1H decoupling [43]. The helical tilt angles for 15N NMR
spectra were calculated using equations previously derived in the
literature [44–47].
2.6. MD simulation setup
Two explicit membrane–water environments were used, POPC
and DMPC. A fully-solvated, pre-equilibrated bilayer of 128 DMPC
lipids and 3655 water molecules (taken from http://moose.bio.
ucalgary.ca/ﬁles/dmpc_npat.pdb) was found to be sufﬁciently large
for the simulation in DMPC. Using a similarly sized POPC box, we
noticed that the lateral diffusion of the hCB1(T377-E416) peptide in
the POPC bilayer during unrestrained dynamics caused the peptide to
move outside of the box. As we were concerned about any periodic
artifacts that may occur from the limited size of the box, a larger
POPC bilayer was produced by replicating and then truncating a fully
pre-equilibrated 8×8×2 POPC patch [48] in PyMOL (DeLano
Scientiﬁc LLC, Palo Alto, CA). This yielded a fully-solvated POPC
bilayer composed of 256 POPC lipid and 7016 water molecules. The
POPC system was fully minimized with steepest descent, then 2 ns of
MD were performed with the phosphorus atom of each lipid
positionally constrained with a force constant of 1000 kJ mol−1 nm−2.
A further 2 ns of unrestrained MD were performed to produce a fully-
solvated, fully-equilibrated POPC bilayer prior to peptide insertion
(see MD details below). The potential energy reached a stable plateauFig. 3. One-dimensional chemical-shift 15N NMR spectra of hCB1(T377-E416) peptide in ph
L404, A407, M411]hCB1(T377-E416) in oriented DMPC bilayers. (B) The spectrum correspon
POPC bilayers. (C) The spectrum corresponding to selectively labeled 15N-[K402, L404, A407
selectively labeled 15N-[A380]hCB1(T377-E416) in oriented DMPC bilayers (D) and in orien
E416) in POPC.after 700 ps, and the area of the xy plane per POPC lipid ﬂuctuated
around 61.3 Å2, which is comparable to the experimental value of
63 Å2 [49]. A reﬁned hCB1(T377-E416) model was constructed using
the rhodopsin crystal structure (PDB ID: 1L9H) [42] as a template in
the “Prime” software package, 1.6 edition (Schrödinger, Inc., New
York, NY).
2.7. MD simulation procedure
hCB1(T377-E416) was embedded into each of the pre-equili-
brated POPC and DMPC lipid bilayers. Helix 7 was placed spanning
the membrane, and helix 8 was oriented along the plane of the
membrane, as suggested by homology modeling [27,28,32]. Any
lipids or water molecules clashing with the peptide were removed.
Each system was made electrically neutral by replacing two water
molecules at the most positive electrostatic potential with two
chloride ions and was minimized with steepest descents to relax
unfavorable contacts between molecules. To achieve stability of the
lipid environment during production dynamics, equilibration MD
was performed for 2 ns, with all heavy atoms in the peptide
positionally restrained with a force constant of 1000 kJ mol−1 nm−2.
Unconstrained production MD was performed for 10 ns on each
system.
All MD simulations were performed in the NPT (isothermal–
isobaric) ensemble with periodic boundary conditions. A temperature
of 298 K was maintained by a Berenden thermostat [50] with time
constant 0.1 ps. Semi-isotropic pressure coupling was used, with the
reference pressure set at 1.0 bar and time constant 5 ps. Coulomb and
short-range neighbor list cut-offs were both set to 0.9 nm, and
Lennard-Jones cut-offs were set to 1.2 nm. The electrostatic interac-
tions were computed with the Particle-Mesh Ewald method [51,52]ospholipid bilayers. (A) The spectrum corresponding to selectively labeled 15N-[K402,
ding to selectively labeled 15N-[K402, L404, A407, M411]hCB1(T377-E416) in oriented
, M411]hCB1(T377-E416) in unoriented POPC bilayers. The spectrum corresponding to
ted POPC bilayers (E). (F) Chemical shift tensor of unoriented 15N-[A380]hCB1(T377-
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0.12 nm. A time-step of 2 fs was used, and pair lists were updated
every 10 steps. The LINCS algorithm [53] was employed to preserve
bond lengths. The simple point charge water model [54] was used in
all simulations. The lipid force ﬁeld parameters were taken from
Berger et al. and Chiu et al. [55,56], and the peptide used the
GROMOS96 force ﬁeld [57]. All simulations were carried out with the
GROMACS program, version 3.2.1 [58,59].Fig. 4. One-dimensional solid-state 15NNMR spectra of site-speciﬁcally 15N-labeledhCB1(T377-
were collected at 35 °C for both DMPC and POPC bilayers. (A) V378, (B) A380, (C) L388, (D) V3
hCB1(T377-E416) in POPC. The corresponding spectra of eachof the six labeled peptides inDMP
399, and (N) chemical shift tensor of unoriented, selectively 15N-labeled hCB1(T377-E416) in D2.8. Simulation analysis
During the production phase of MD, snapshots were taken every
2 ps, resulting in 5000 snapshots for each 10 ns trajectory. The top of
helix 7 was deﬁned as the center of mass of the ﬁve Cα atoms of
residues V378, F379, A380, F381, and C382 of the hCB1(T377-E416)
peptide. The other end was described by the center of mass of the ﬁve
Cα atoms of I395, I396, Y397, A398 and L399. Similarly, the inceptionE416) in orientedDMPCand POPC phospholipid bilayers. The 15N-labeled spectra displayed
92, (E) A398, (F) L399, and (G) chemical shift tensor of unoriented, selectively 15N-labeled
C phospholipid bilayers are displayed. (H) V378, (I) A380, (J) L388, (K) V392, (L) A398, (M)
MPC. The spectra were referenced to external 15NH4(SO4)2 at 27 ppm.
Table 1
15N chemical shift data [in ppm relative to (15NH4)2SO4 solution referenced to 27 ppm]
from the single-site 15N-labeled aligned samples of hCB1(T377-E416)
Membrane Sites
V378 A380 L388 V392 A398 L399
DMPC 183 178 179 174 181 189
POPC 207 201 195 192 184 197
DMPC=mean values for triplicate scans for each residue ±3 ppm.
POPC=mean values for triplicate scans for each residue ±2 ppm.
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residues D403, L404, R405, H406 and A407, and the other end was
described by the center of mass of the ﬁve Cα atoms of F408, R409,
S410, M411 and F412. With these deﬁnitions, the tilt of helix 7 relative
to the membrane axis and the angle between helices 7 and 8 were
calculated using the g_bundle analysis tool in GROMACS [58,59].
3. Results and discussion
3.1. Secondary structure of hCB1(T377-E416) in phospholipid bilayer
model membranes
CD is a key method for measuring peptide helix formation, since
CD spectra reﬂect the quantity of peptide secondary structure (α-
helices, β-sheets, β-turns) [37]. The CD spectra of the peptide 40-mer
corresponding to hCB1(T377-E416) in TFE and POPC evidenced two
bands at 192 nm and 220 nm, characteristic of an α-helical structure
(Fig. 1). The α-helical content of hCB1(T377-E416) was calculated to
be 67% in TFE and 41% in POPC. The lower α-helical content in the
latter instance may be due to a scattering effect of the phospholipids.
This result is in accord with a previous observation [29] that the CB1-
receptor helix 8 assumes an α-helical character in an amphipathic
environment.
3.2. 15N NMR analysis of hCB1(T377-E416) orientation in DMPC and
POPC bilayers
Proton-decoupled solid-state 15N NMR spectroscopy of oriented
membrane peptides is useful for investigating polypeptide backbone
secondary structure and topology [39]. The NMR spectrum in Fig. 2A
was obtained at 35 °C from an oriented sample of hCB1(T377-E416)
peptide with six 15N-labeled residues (A380, A398, K402, L404, A407,
M411) in DMPC bilayers mechanically aligned on glass plates. There
are two relatively broad resonances in the spectrumdue to the six 15N-
labeled residues which appear at 185 and 60 ppm, respectively. Fig. 2B
was obtained from six 15N-labeled hCB1(T377-E416) peptide residues
in aligned POPC bilayers and also exhibits two broad resonances, with
chemical shifts at 215 and 83 ppm. The resonance peak-intensity ratio
for the spectra in Fig. 2A and B is ∼1:2. Their chemical shift values
suggest that two out of the six 15N-labeled amino acid residues are
oriented with the long molecular axis parallel to the bilayer normal
and the external magnetic ﬁeld, whereas the other four residues are
oriented perpendicular to the bilayer normal. Fig. 2C represents the
same six 15N-labeled hCB1(T377-E416) peptide in unoriented POPC
phospholipid bilayers and is used for direct comparison of the
frequencies that provided the orientational constraints in Fig. 2A
and B. Here, the unoriented spectrum spans from 225 to 50 ppm,
indicative of a peptide backbone that is quite rigid within the
membrane in the NMR time scale. The aggregate NMR data in Fig. 2
suggest that the hCB1(T377-E416) peptide in DMPC and POPC bilayers
encompasses membrane-spanning hydrophobic and membrane-
ﬂanking hydrophilic regions.
In order to identify which of the above six labeled residues are
either embedded within or disposed externally to the bilayer, we
synthesized hCB1(T377-E416) with one 15N label at A380 and another
peptide with four 15N labels at K402, L404, A407 and M411 and
separately incorporated the labeled peptides into oriented DMPC or
POPC subtypes. As shown in Fig. 3A, 15N-[K402, L404, A407, M411]
hCB1(T377-E416) evidences an in-plane helix with its N–H resonance
at 60 ppm and near the upﬁeld end (δ11) of the powder pattern
spectrum (Fig. 3C) in DMPC. Fig. 3B shows the orientation of 15N-
[K402, L404, A407,M411]hCB1(T377-E416) in POPC, which displays an
in-plane N–H bond resonance peak at 83 ppm. The average chemical
shift of ~70 ppm from the membrane preparations is reﬂective of a
peptide residing practically on the membrane surface. 15N-[A380]
hCB1(T377-E416) was separately incorporated into DMPC and POPCbilayers to determine the orientation of the TM peptide in these two
lipid environments. In DMPC, 15N-[A380]hCB1(T377-E416) displayed
a chemical shift at 185 ppm (Fig. 3D) and a resonance at 215 ppm in
POPC (Fig. 3E) near the downﬁeld end (δ33) of the powder pattern
spectrum (Fig. 3F). The results are consistent with the spectra in Fig. 2
and also with the MD simulation data (below), indicating that the
helix 7 microdomain (T311-L399) (which includes 15N-[A380]) is in a
transmembrane orientation, whereas helix 8 (D403-F412) (which
includes 15N-[K402, L404, A407, and M411]) is oriented along the
plane of the membrane. Additionally, the increase in chemical shift
from 185 ppm to 215 ppm upon incorporation of 15N-[A380]hCB1
(T377-E416) into the longer-chain phospholipid bilayer indicates a
substantial difference in orientation of the peptide between DMPC
and POPC bilayers. The combined 15N NMR and MD data support
conclusion that the hCB1(T377-E416) peptide consists of two α-
helical segments oriented nearly orthogonally to each other. These
results are consistent with the high-resolution structure of the same
peptide in DMPC bilayers with a peptide-to-lipid molar ratio of 1:50
(data not shown).
The helical tilt angle of hCB1(T377-E416) within the phospholipid
bilayer environment was determined by using a total of six peptide
samples, each with a single 15N-labeled residue in the TM peptide
segment. The labeled peptides were introduced into POPC and DMPC
bilayers mechanically aligned between thin glass plates. Fig. 4 shows
the orientation of all six (V378, A380, L388, V392, A398, L399) speciﬁc
15N-labeled peptides within each membrane environment. The
chemical shifts were extracted from the aligned spectra and recorded
in Table 1 to aid calculation of the tilt angles. In POPC bilayers (Fig. 4A
to F), the NMR spectra evidenced single line resonances with
linewidths ranging from 6 to 20 ppm, suggesting a single conforma-
tion within the phospholipid bilayer. However, in DMPC bilayers, the
resonance lines for the same sets of peptides are broad (Fig. 4G to L),
suggesting conformational heterogeneity. This conformational dis-
tinction is supported by estimates madewith the approach of Smith et
al. [60] that the disorder in the alignment of the bilayers parallel to the
glass plates (i.e., mosaic spread) is modest, ±0.3°. In both sets of
spectra for DMPC and POPC bilayers, all selected residues exhibited
15N peaks near the δ33 edge, indicating a TM hCB1(T377-E416)
orientation. Increased tilt angles of peptides within membranes are
often associated with decreased chemical shifts in aligned spectra
[61]. In the current study, we indeed observed decreased chemical
shifts in DMPC vs. POPC bilayers (Fig. 3).
The aligned 15N chemical-shiftmeasurements and thechemical-shift
tensor elements fromtheunorientedDMPCandPOPCspectrawere used
to determine precise protein helical tilt angles using established
methods [62]. This determination was made with the assumption that
hCB1(T377-E416) is a continuous α-helix within the membrane
environment. As shown in the contour plots (Fig. 5), there is only one
minimum identiﬁed to predict the orientation of hCB1(T377-E416) in
DMPC and POPC bilayers. In Fig. 5A, the 15N angle calculation shows a
unique root-mean-square deviation (RMSD) minimum on the surface
corresponding to τ=26±2° and ρ=−250° in DMPC and τ=11±4°
and ρ=50° in POPC. These values correspond to the most likely helical
tilt orientations of hCB1(T377-E416) in DMPC and POPC bilayers.
Fig. 5. Contour plots representing the 15N chemical shifts calculated for the rotation, ρ from 0° to 360°, and for tilt angle, τ from 0° to 90°. The root-mean-square deviation (RMSD)
between the experimental and calculated chemical shifts was calculated for each ρ and τ pair and plotted as τ (y-axis) versus ρ (x-axis). (A) The DMPC sample plot has a minimum at
τ=26° and ρ=−250°. (B) The POPC plot shows a minimum at τ=11° and ρ=50°.
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The difference in calculated tilt angles of hCB1(T377-E416) in
DMPC vs. POPC bilayers may reﬂect the difference in phospholipid
bilayer thickness. The DMPC bilayer carbonyl-to-carbonyl thickness is
about 23 Å, whereas the POPC bilayer is 27 Å thick [63]. Thus, the
transmembrane region of hCB1(T377-E416) might display greater tiltFig. 6. Snapshots taken after 10-ns MD production of hCB1(T377-E416) in (A) POPC or (B) DM
shown in gray. hCB1(T377-E416) is shown in green. The shorter hydrophobic thickness of DM
without the membrane matrix.in the DMPC membrane than in the POPC membrane mimetic as a
means to avoid hydrophobic mismatch between the shorter-chain
DMPC lipid and the hydrophobic TM hCB1(T377-E416) region. In
both MD simulations, helix 8 (D403-F412) is oriented parallel to the
plane of the phospholipid membrane surface. The side-chains of the
polar residues of the juxtamembrane segment (K402, H406, R409)
are positioned among the head group region of the bilayer, whereasPC. The carbon atoms of POPC are shown in teal, whereas the carbon atoms of DMPC are
PC causes a kink in hCB1 (T377-E416) helix 7 at P394, as depicted in panels (C) vs. (D)
1166 E.K. Tiburu et al. / Biochimica et Biophysica Acta 1788 (2009) 1159–1167the non-polar side-chains (L404, F408, M411) are in the lipophilic tail
region of the bilayer. These peptide–lipid interactions appear to
orient helix 8 in the bilayer. The side chain of R400 at the terminus of
helix 7 forms a salt bridge to the phospholipid phosphate moiety, an
interaction that may help tether the helix in the bilayer. The span of
the POPC bilayer was sufﬁcient to accommodate an extended TM
helix 7 (T377-L399) within the membrane bilayer (Fig. 6A and C). In
the thinner, DMPC bilayer (Fig. 6B), the TM region of hCB1(T377-
E416) is kinked at P394 (Fig. 6D). From analysis of the MD
trajectories, the tilt angle of helix 7 was determined to be 13±3°
in the POPC bilayer and 28±5° in the DMPC bilayer. In the POPC
bilayer, the angle between helices 7 and 8 was 89±5°. In the DMPC
bilayer, if the entirety of helix 7 is taken into account, the inter-helix
angle was 119±7° because of the kink and helical tilt of the TM helix
7. However, the angle between helix 8 and the region of helix 7
proximal to it and beyond the kink was 89±4°, similar to that found
in the POPC bilayer.
3.4. Inﬂuence of membrane hydrophobic thickness on hCB1(T377-E416)
backbone ﬂexibility
The 15N lineshapes in all 15N-labeled sites for hCB1(T377-E416)
in the DMPC environment were slightly broader than those
obtained for the peptide in the POPC bilayer. This linewidth
broadening may reﬂect factors such as increased mosaic spread
and imperfection of the peptide's α-helical structure, which may
result in conformational heterogeneity associated with differential
protein–lipid interactions. Nonetheless, the aligned spectra clearly
demonstrate that there are two hCB1(T377-E416) α-helices in two
distinct environments. The semi-quantitative orientation of the
helices with respect to each other is 91±6° in the POPC bilayer and
120±5° in the DMPC bilayer. These results compare favorably with
the MD simulation data (above) and indicate that the two helices
are roughly orthogonal to each other in their membrane environ-
ment. Nonetheless, caution should be exercised in comparing the
MD and NMR data, for differences in the extent of hydration under
the two experimental conditions may have inﬂuenced peptide
insertion/conformation.
The orientation of hCB1 TM helix 7 within the membrane
bilayer and relative to other hCB1 helices would likely inﬂuence
ligand recognition by this GPCR. Indeed, a bend in TM helix 7 has
been suggested to be critical for selective, high-afﬁnity binding of
CB1-receptor agonists [32]. We have deﬁned in this study an
energy-minimized interaction of hCB1(T377-E416) with DMPC and
POPC bilayers. A key feature of the hCB1(T377-E416) peptide
uncovered is its ability to orient TM helix 7 conformation
cooperatively with its phospholipid bilayer environment to avoid
hydrophobic mismatch. The transmembrane regions of most GPCRs
contain conserved NP(X)nY motifs, and proline residues are α-
helical destabilizers in globular proteins [10,11]. The TM NP(X)nY
motif in hCB1 helix 7 could be important to the conformational
changes we have observed in hCB1(T377-E416) between phospho-
lipid membrane systems: it may allow a kink in a TM helix if helix
tilting alone is not enough to relieve hydrophobic mismatch,
especially in the case of a lengthy TM domain. Thus, multiple
mechanisms could play a role in helix conformational changes to
ensure hydrophobic matching by changing overall polypeptide span
(Fig. 6). It is not surprising, therefore, that there are conserved
proline residues in most GPCRs that might serve this purpose
[10,11,64]. We postulate that the kink at P394 is crucial for
conformational modulation of hCB1, which may occur in concert
with additional structural rearrangements in other hCB1 helices.
Since the present studies were performed in model membranes,
however, the general relevance of these results to more complex
and variable biological membrane environments will require future
experimental conﬁrmation.4. Conclusion
Our solid-state NMR and computational data on the orientation of
the 40-mer peptide hCB1(T377-E416) in a model membrane POPC
bilayer clearly indicate that the ﬁrst 23 amino acid residues, a segment
of TM helix 7, form an α-helical structure embedded within the
bilayer and oriented with a tilt angle of approximately 11° with
respect to the normal membrane axis. The remaining amino acids
constituting helix 8 are outside the hydrophobic core, approximately
orthogonal to helix 7 and oriented parallel to the membrane surface.
When hCB1(T377-E416) is introduced into a narrower (DMPC) bilayer
membrane mimetic, a distinct change in the orientation of the
peptide's TM segment was observed, with a greater tilt angle of 26°.
The increased tilt reﬂected a response to avoid hydrophobic mismatch
and was likely affected by a kink at P394. Our results thus constitute
initial demonstration that the membrane bilayer plays a role in
modulating the conformation and orientation of a CB-receptor TM
helix. Given the importance of TM helix 7 to hCB1 ligand recognition
[32], cooperative changes in the orientation of GPCR helices based on
membrane thickness likely inﬂuence hCB1 function.
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